Silver Nanoparticles Bio-genesis from Colpomenia sinuosa and its in-vivo Anti-tumor Efficacy on DLA Inoculated tumor in albino mice
DOI:
https://doi.org/10.37285/ijpsn.2022.15.5.8Abstract
Objective: The anti-tumor activity of biosynthesized silver nanoparticles from marine brown seaweed Colpomenia sinuosa against DLA (Dalton’s lymphoma ascites) induced tumor was investigated.
Methods:
The biosynthesis of silver nanoparticles from marine macroscopic red seaweed C. sinuosa was synthesized by the green synthesis method and characterized by UV–Vis spectroscopy, Fourier transform infrared (FT-IR) spectroscopy, X-ray diffraction, Thermogravimetric analysis (TGA), scanning electron microscope (SEM), and transmission electron microscopy (TEM). The complete study was done by purchasing 20 to 25 g of male Swiss albino mice from KMCP College of Pharmacy animal experimental laboratory. The Daltons’ lymphoma ascites cell line induced tumor in albino mice was evaluated for anti-tumor activity with the biogenic silver nanoparticles from marine brown seaweed Colpomenia sinuosa and was estimated for tumor cell count, body heaviness, Life expectancy, haematological and biochemical factors, histologic analysis of liver using H&E and PAS staining.
Results: The oral administration of the biosynthesized silver nanoparticles from marine brown seaweed Colpomenia sinuosa at 50 mg per kg body weight albino mice were given daily for 14 days. The haematological and biochemical factors along with bodyweight of the animal, cell count (tumor), and cell volume (packed) were analyzed and compared with Dalton’s lymphoma control group of mice. The treatment control group mice with biosynthesized silver nanoparticles exhibited an increase in haematological factors, a decrease in white blood cells, and normalcy of biochemical factors compared to Dalton’s lymphoma group mice. The reduction in body weight of mice, cell count (tumor), and cell volume (packed) were also observed in treatment group mice with biosynthesized silver nanoparticles as compared to Dalton’s lymphoma group mice.
Conclusion: The eco-friendly and green synthesis methodology of biosynthesized silver nanoparticles from Colpomenia sinuosa reversed the haematological, and biochemical factors to near normal range against the DLA control group proving the efficacy of the studies. The improvement in the body weight and the life expectancy of the animals also confirmed the anti-tumor efficacy of the biogenic silver nanoparticles.
Downloads
Metrics
Keywords:
Anti-tumor, Colpomenia sinuosa, AgNps, Dalton’s lymphoma
Published
How to Cite
Issue
Section
References
Agarwal RC, Rachana J, Wasim R, and Ovais M (2009). Anti-Carcinogenic effects of Solanum lycopersicum fruit extract on Swiss albino and C57B1 Mice. Asian Pacific J Cancer Prev 10: 379-382
Ahmed S, Ahmad M, Swami BL and Ikram S (2016). A review on plants extract mediated synthesis of silver nanoparticles for antimicrobial applications: A green expertise. Journal of Advanced Research 7(4): 17-28.
Alivisatos P (2004). The use of nanocrystals in biological detection. Nat Biotechnol 22: 47-52.
Appleman D, Edwin R, Skavinski, Abraham M, and Stein (1950). Catalase studies on normal and cancerous rats. Cancer Research 10: 498-505.
Bhuvaneswari S and Murugesan S (2012). Antitumour activity of Chondrococcus hornemannii and Spyridia fusiformis on Dalton’s lymphoma ascites in mice. Bangladesh J Pharmacol. 7: 173–177.
Buttacavoli M, Albanese NN, Di Cara G, Alduina R, Faleri C, Gallo M, Pizzolanti G, Gallo G, Feo S, Baldi F, and Cancemi P (2017). Anticancer activity of bio generated silver nanoparticles: an integrated proteomic investigation. Oncotarget 9(11): 9685–9705.
Chitra V., Shrinivas S, and Nandu K (2009). Evaluation of Anticancer activity of Vitexnegundo study. Intl J Pharm Tech Res 1(4): 1485-1489.
Clarkson BD and Burchenal JH (1965). Progress in leukemias. Prog Clin Cancer 10: 625–633.
Daniel MC and Astruc D (2004). Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 104: 293-346.
Feroze N, Arshad B, Younas M, Afridi MI, Saqib S, and Ayaz A (2020). Fungal mediated synthesis of silver nanoparticles and evaluation of antibacterial activity. Microscopy Research and Technique 83(1): 72-80.
Feynman R (1991). There's plenty of room at the bottom. Science 254: 1300-1301.
Gomathi AC, Rajarathinam SX, Sadiq AM, and Rajeshkumar S (2020). Anticancer activity of silver nanoparticles synthesized using aqueous fruit shell extract of Tamarindus indica on MCF-7 human breast cancer cell line. Journal of Drug Delivery Science and Technology 55: 101376.
Gopinath P, Gogoi SK, Chattopadhyay A, and Ghosh SS (2008). Implications of silver nanoparticle-induced cell apoptosis for in vitro gene therapy. Nanotechnology 19(7): e.075104.
Hebeish A, El-Rafie MH, El-Sheikh MA, Seleem AA, and El-Naggar ME (2014). Antimicrobial wound dressing and anti-inflammatory efficacy of silver nanoparticles. International Journal of Biological Macromolecules 65: 509-515.
Hogland HC (1982). Haematological complication of cancer chemotherapy. Semin Oncol 9: 95–102.
Igaz N, Kovács D, and Rázga Z (2016). Modulating chromatin structure and DNA accessibility by deacetylase inhibition enhances the anti¬-cancer activity of silver nanoparticles. Colloids Surf B Biointerfaces 146: 670–677.
Iravani S, Korbekandi H, Mirmohammadi SV, and Zolfaghari B (2014). Synthesis of silver nanoparticles: chemical, physical and biological methods. Research in Pharmaceutical Sciences, 9(6): 385–406.
Ivanova N, Gugleva V, Dobreva M, Pehlivanov I, Stefanov S, and Andonova V (2018). Silver nanoparticles as multi-functional drug delivery systems. In Nanomedicines IntechOpen.
Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, and Paknikar KM (2009). Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Molecular Pharmaceutics 6(5): 1388-1401.
Jason RM and Raymond ND (2004) Cancer chemoprevention: myth or reality? Drug Discovery Today: Therapeutic Strategies 1(4): 403-410.
Li S, Shen Y, Xie A, Yu X, Qiu L, and Zhanga L (2007). Green synthesis of silver nanoparticles using Capsicum annuum L. extracts. Green Chemistry 9: 852-858.
Love JC, Estroff LA, Kriebel JK, Nuzzo RG, and Whitesides GM (2005). Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chem Rev 105: 1103–1169.
Mary KT, Kuttan G, and Kuttan K (1994). Partial purification of Tumuor reducing principle from Helicanthis elasticus. Cancer Letter 81: 53-57
Mirkin CA and Taton TA (2006). Semiconductors meet biology. Nature 405: 626–627.
Muthu IS, Selvaraj BMK, Kalimuthu K, and Sangiliyandi G (2010). Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumour model. Intl J Nanomed 5: 753–762.
Nie S, Xing Y, Kim GJ, .and Simons JW (2007). Nanotechnology applications in cancer. Annu Rev Biomed Eng 9: 257–288.
Rajesh KS, Malrakodi C, and Venkat KS (2017). Synthesis and characterization of silver nanoparticles from marine brown seaweed and its antifungal efficiency against clinical fungal pathogens. Asian J Pharm Clin Res 10(2): 190-193.
Reitman S and Frankel S (1957). A colorimetric method for the determination of serum glutamic oxaloacetate and glutamic pyru trasnaminases. American J Clin Path 28: 56-63.
Rutberg FG, Dubina MV, and Kolikov VA (2008). Effect of silver oxide nanoparticles on tumour growth in vivo. Dokl Biochem Biophys 421: 191–193.
Sangiliyandi G, Jung HP, Jae WH, and Jin-Hoi K (2015). Comparative assessment of the apoptotic potential of silver nanoparticles synthesized by Bacillus tequilensis and Calocybe indica in MDA-MB-231 human breast cancer cells: targeting p53 for anticancer therapy. Intl J Nanomed 10: 4203–4223.
Santhosh KH, Senthil KN, and Reghu CH (2007). Anti tumuor activity of Methanolic extract of Hypericum hookerianum on EAC Cell line in Swiss albino mice. J Pharmacological Sci 103: 354-359.
Sathiyanarayanan L, Shinnathambi, Arulmozi, and Chidhambarnathan N (2006). Anti-carcinogenic activity of LeptadeniareticulataI against Dalton’s ascitic lymphoma. Iranian J Pharm Toxicol 6: 133–136.
Seigneuric R, Markey L, Nuyten DS, Dubernet C, and Evelo CT (2010). From nanotechnology to nanomedicine: applications to cancer research. Curr Mol Med 10(7): 640-652.
Souza TA, Franchi LP and Rosa LR (2016). Cytotoxicity and genotoxicity of silver nanoparticles of different sizes in CHO-K1 and CHO-XRS5 cell lines. Mutat Res Genet Toxicol Environ Mutagen 795: 70–83.
Unnikrishnan MC and Kuttan R (1990). Tumuor reducing and anti-carcinogenic activity of selected species. Cancer Letter 51: 85-89.
Vishnu Kiran M and Murugesan S (2014). Biosynthesis of silver nanoparticles from marine alga Colpomenia sinuosa and its antibacterial efficacy. International Journal of Current Microbiology and Applied Sciences 3(4): x-xx.
Vishnu Kiran M and Murugesan S (2014). Biological synthesis of silver nanoparticles from marine alga Colpomenia sinuosa and its in vitro anti-diabetic activity. American Journal of Bio-Pharmacology Biochemistry and Lifesciences 3(1): 1-7.
Vishnu Kiran M and Murugesan S (2014). In vitro Antioxidant activity of silver nanoparticles from Colpomenia sinuosa and Halymenia porphyroides. World Journal of Pharmaceutical Sciences 2(8): 817-820.
Vishnu Kiran M and Murugesan S (2014). In vitro cytotoxic activity of silver nanoparticle biosynthesized from Colpomenia sinuosa and Halymenia porphyroides using DLA and EAC cell lines. World Journal of Pharmaceutical Sciences 2(9): 926-930.
Vishnu Kiran M and Murugesan S (2020). Biosynthesis and characterization of silver nanoparticles from marine macroscopic brown seaweed Colpomenia sinuosa (Mertens ex Roth) Derbes and Solier. J Adv Chem Sci 6(1): 663–666.
Vishnu Kiran M and Murugesan S (2020). Biosynthesis and characterization of silver nanoparticles from marine macroscopic red seaweed Halymenia porphyroides Boergesen (crypton). J Nanosci Tech 6(2): 886–890.
Wang MD, Shin DM, Simons JW, and Nie S (2007) Nanotechnology for targeted cancer therapy. Expert Rev Anticancer Ther 7: 833–837.
Zlatkis A, Zak B, and Boyle AJ (1953). A new method for the direct determination of serum cholesterol. J Lab Clin Med 41: 486 – 492.
